Abiomed Inc. (NSDQ:ABMD) started a new education program for hospitals.
The Danvers, Massachusetts-based company is selecting healthcare institutions to be training centers for its Impella cardiac assist devices. Abiomed wants hospitals to adopt protocols that include the early administration of its heart pumps for patients with distressed hearts. Abiomed said use of its devices reduces re-admissions and improves heart muscle recovery.
The first healthcare provider to sign up is Harrisburg, Pennsylvania-based PinnacleHealth, according to the company.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“This collaborative program will educate healthcare institutions across the U.S. on the value of treating patients with emergent hemodynamic support to allow earlier intervention that achieves the outcome of heart muscle recovery for their cardiac care programs,” CEO Michael Minogue said in prepared remarks.
In July, Abiomed CTO Dr. Thorsten Siess told MassDevice that the device’s sophistication warrants the focused proselytizing.
“It’s not about giving it to everyone, but making sure that the people who get it have appropriate training. Only then will we be able to sustain good outcomes,” Siess said.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
